MOA of ADCs and Their Rationale for Use in Patients with Cancer

University of Nebraska Medical Center, Bio Ascend
3/7/22, 4:00 PM
America/Chicago UTC -5

Description

This activity is jointly provided by the University of Nebraska Medical Center and Bio Ascend. This activity is supported by independent educational grants from SeaGen, Inc., ADC Therapeutics, Gilead Sciences, Inc.

Previous registration necessary?

NO

YES
Simultaneous translation ?

NO

YES
Will it be recorded?
NO
YES

Sara A. Huvitz

MOA of ADCs and Their Rationale for Use in Patients with Cancer

Inglês

 

Speakers

Giuseppe Curigliano, Sven de Vos

 

Link to the Event

Banner to the Event

MOA of ADCs and Their Rationale for Use in Patients with Cancer